The stock was sold at an average price of $81.03, for a total transaction of $2,406,185.85. The company had revenue of $29498.00 million for the quarter, compared to analysts expectations of $29719.29 million. The company’s institutional ownership is monitored at 0%. Company has a market cap of $88,252 M. The median estimate represents a -8.09% decrease from the last price of 21.76.
Advertisement
Many Wall Street Analysts have commented on Walgreens Boots Alliance Inc. Now the company has earned “Buy” from 6 equity analysts. 1 analysts call it Overweight, while 1 think it is Underweight. Underperform rating was given by 0 analyst and Outperform rating was given by 7 analyst.
Walgreens Boots Alliance Inc. says it remains “actively engaged” with the Federal Trade Commission as it reviews the deal. The company traded as low as $92.90 on the day. Over the one year trading period, the stock has a high price of $96.88 and its low price is recorded at $59.75. The stock has a consensus analyst price target of $91.98for twelve month.
Currently, the stock carries a price to earnings ratio of 28.13, a price to book ratio of 2.86, and a price to sales ratio of 0.75. The business’s revenue for the quarter was up 2.4% on a year-over-year basis.
Walgreens Boots Alliance is the largest retail pharmacy, health and daily living destination in the US and Europe and, together with its equity method investments*, employs more than 370,000* people and has a presence in more than 25* countries. Company shares were Reiterated by Deutsche Bank on Aug 30, 2016 to “Buy”, Firm has raised the Price Target to $ 94 from a previous price target of $93.Shares were Reiterated by FBR Capital on Jul 7, 2016 to “Mkt Perform” and Lowered the Price Target to $ 85 from a previous price target of $90.Walgreens Boots Alliance Inc was Resumed by BofA/Merrill to “Buy” on Jun 7, 2016. The stock is a Buy among 12 brokerage firms polled by Factset Research. Walgreens Boots Alliance Inc makes up approx 0.34% of Usca Ria’s portfolio.Argent Trust Co reduced its stake in WBA by selling 465 shares or 1.37% in the most recent quarter. Barclays PLC lifted their price objective on shares of Walgreens Boots Alliance from $76.00 to $79.00 and gave the company an “equal weight” rating in a report on Thursday, July 7th.
Advertisement
TheStreet Ratings rated Rite Aid stock as a “hold” with a ratings score of C.
